gC1qR/HABP1/p32 Is a Potential New Therapeutic Target Against Mesothelioma

Mesothelioma is an aggressive cancer of the serous membranes with poor prognosis despite combination therapy consisting of surgery, radiotherapy, and platinum-based chemotherapy. Targeted therapies, including immunotherapies, have reported limited success, suggesting the need for additional therapeu...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Ellinor Peerschke, Kenneth Stier, Xiaoyu Li, Evelyn Kandov, Elisa de Stanchina, Qing Chang, Yuquan Xiong, Katia Manova-Todorova, Ning Fan, Afsar Barlas, Berhane Ghebrehiwet, Prasad S. Adusumilli
Format:	Artigo
Jezik:	Inglês
Izdano:	Frontiers Media S.A. 2020-08-01
Serija:	Frontiers in Oncology
Teme:	mesothelioma complement gC1qR/HABP1/p32 monoclonal antibody therapy therapeutic target
Online dostop:	https://www.frontiersin.org/article/10.3389/fonc.2020.01413/full
Oznake:	Označite Brez oznak, prvi označite!